| Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia RG Owen, SP Treon, A Al-Katib, R Fonseca, PR Greipp, ML McMaster, ... Seminars in oncology 30 (2), 110-115, 2003 | 1107 | 2003 |
| Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's … RA Kyle, SP Treon, R Alexanian, B Barlogie, M Björkholm, M Dhodapkar, ... Seminars in oncology 30 (2), 116-120, 2003 | 381 | 2003 |
| Polymorphisms in Fc RIIIA(CD 16) Receptor Expression Are Associated With Clinical Response to Rituximab in Waldenstrom's Macroglobulinemia SP Treon, M Hansen, AR Branagan, S Verselis, C Emmanouilides, ... Journal of Clinical Oncology 23 (3), 474-481, 2005 | 306 | 2005 |
| Characterization of familial Waldenström's macroglobulinemia SP Treon, ZR Hunter, A Aggarwal, EP Ewen, S Masota, C Lee, DD Santos, ... Annals of Oncology 17 (3), 488-494, 2006 | 222 | 2006 |
| Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia: results of WMCTG Trial 03-248 SP Treon, ZR Hunter, J Matous, RM Joyce, B Mannion, R Advani, D Cook, ... Clinical cancer research 13 (11), 3320-3325, 2007 | 220 | 2007 |
| Extended rituximab therapy in Waldenström's macroglobulinemia SP Treon, C Emmanouilides, E Kimby, A Kelliher, F Preffer, AR Branagan, ... Annals of Oncology 16 (1), 132-138, 2005 | 200 | 2005 |
| Clonal immunoglobulin against lysolipids in the origin of myeloma S Nair, AR Branagan, J Liu, CS Boddupalli, PK Mistry, MV Dhodapkar New England Journal of Medicine 374 (6), 555-561, 2016 | 199 | 2016 |
| Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia SP Treon, MA Gertz, M Dimopoulos, A Anagnostopoulos, J Blade, ... Blood 107 (9), 3442-3446, 2006 | 197 | 2006 |
| Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia SP Treon, AR Branagan, L Ioakimidis, JD Soumerai, CJ Patterson, ... Blood, The Journal of the American Society of Hematology 113 (16), 3673-3678, 2009 | 181 | 2009 |
| Paradoxical increases in serum IgM and viscosity levels following rituximab in Waldenstrom's macroglobulinemia SP Treon, AR Branagan, Z Hunter, D Santos, O Tournhilac, KC Anderson Annals of oncology 15 (10), 1481-1483, 2004 | 176 | 2004 |
| Thalidomide and rituximab in Waldenstrom macroglobulinemia SP Treon, JD Soumerai, AR Branagan, ZR Hunter, CJ Patterson, ... Blood, The Journal of the American Society of Hematology 112 (12), 4452-4457, 2008 | 156 | 2008 |
| Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice R Das, T Strowig, R Verma, S Koduru, A Hafemann, S Hopf, MH Kocoglu, ... Nature medicine 22 (11), 1351-1357, 2016 | 149 | 2016 |
| Lenalidomide and rituximab in Waldenstrom's macroglobulinemia SP Treon, JD Soumerai, AR Branagan, ZR Hunter, CJ Patterson, ... Clinical cancer research 15 (1), 355-360, 2009 | 148 | 2009 |
| Genomic landscape of Waldenström macroglobulinemia and its impact on treatment strategies SP Treon, L Xu, ML Guerrera, C Jimenez, ZR Hunter, X Liu, M Demos, ... Journal of Clinical Oncology 38 (11), 1198, 2020 | 144 | 2020 |
| Mast cells in Waldenstrom's macroglobulinemia support lymphoplasmacytic cell growth through CD154/CD40 signaling O Tournilhac, DD Santos, L Xu, J Kutok, YT Tai, S Le Gouill, L Catley, ... Annals of oncology 17 (8), 1275-1282, 2006 | 142 | 2006 |
| Long-term follow-up of ibrutinib monotherapy in symptomatic, previously treated patients with Waldenström macroglobulinemia SP Treon, K Meid, J Gustine, G Yang, L Xu, X Liu, CJ Patterson, ... Journal of Clinical Oncology 39 (6), 565, 2021 | 139 | 2021 |
| Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia MA Gertz, A Anagnostopoulos, K Anderson, AR Branagan, M Coleman, ... Seminars in oncology 30 (2), 121-126, 2003 | 138 | 2003 |
| Consensus treatment recommendations from the tenth International Workshop for Waldenström Macroglobulinaemia JJ Castillo, RH Advani, AR Branagan, C Buske, MA Dimopoulos, S D'Sa, ... The Lancet Haematology 7 (11), e827-e837, 2020 | 124 | 2020 |
| Hyperviscosity-related retinopathy in Waldenström macroglobulinemia MN Menke, GT Feke, JW McMeel, A Branagan, Z Hunter, SP Treon Archives of ophthalmology 124 (11), 1601-1606, 2006 | 114 | 2006 |
| Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia D Weber, SP Treon, C Emmanouilides, AR Branagan, JC Byrd, J Bladé, ... Seminars in oncology 30 (2), 127-131, 2003 | 108 | 2003 |
